AI Drug Discovery
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Unlock AI drug discovery insights. Track global pharma market trends, investment opportunities, and regulatory impacts for your BD strategy.
Showing 1–3 of 3 articles
Quick answer
NovaPharmaNews AI Drug Discovery hub for NMPA covers 3 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Insilico Medicine's Rentosertib Inhalation Solution Receives IND Clearance for First AI-Driven Direct-to-Lung Clinical Trial
Sanyou AI-STAL 2.0 Reduces Antibody Discovery Time from Months to 14 Days in Drug Development Breakthrough
Gene Expression Analysis Market Reaches $5.93 Billion by 2031, Driving Drug Discovery Innovation
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.